[Federal Register: January 13, 2005 (Volume 70, Number 9)]
[Notices]
[Page 2407-2410]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13ja05-71]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement Open Season 02060-FY05]
National Cancer Prevention and Control Program; Notice of
Availability of Open Season Funds
LOI Deadline: January 28, 2005.
Application Deadline: February 28, 2005.
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2005 funds for an Open Season for the
National Cancer Prevention and Control Program (NCPCP) cooperative
agreement program previously announced under Program Announcement 02060
(Henceforth referred to as ``PA 02060''). This program addresses the
``Healthy People 2010'' focus area(s) related to cancer.
PA02060 was published in the Federal Register on April 23, 2002,
Volume 67, Number 78, pages 19932-19950. Amendment 1 was published May
23, 2002, Amendment 2 was published January 2, 2003, and Amendment 3
was published on January 20, 2004. Applicants may access the amended
version of PA 02060, along with this Open Season announcement, on the
CDC Web site, Internet address: http://www.cdc.gov. Click on
``Funding,'' then ``Grants and Cooperative Agreements.''
Sections A.-F. of original PA 02060 are superceded by the Sections
A.-F. published in this announcement.
The NCPCP will assist States/District of Columbia/Tribes/
Territories in developing, implementing, maintaining, enhancing,
integrating, and evaluating a cancer program inclusive of cancer
surveillance, prevention and early detection programs, and which
focuses on eliminating health disparities. The purpose of each of the
three programmatic components within the NCPCP follows.
A.1. National Comprehensive Cancer Control Programs (NCCCP)
The NCCCP component supports the planning and implementation of
[[Page 2408]]
comprehensive cancer control activities. CDC defines comprehensive
cancer control as an integrated and coordinated approach to reduce the
incidence, morbidity and mortality of cancer through prevention, early
detection, treatment, rehabilitation, and palliation.
A.2. National Breast and Cervical Cancer Early Detection Program
(NBCCEDP)
The NBCCEDP component supports the development of systems to assure
breast and cervical cancer screening for low income, underserved, and
uninsured women with special emphasis on reaching those who are
geographically or culturally isolated, older, or members of racial/
ethnic minorities. Components of the NBCCEDP include program
management; screening & diagnostic services, to include case
management, tracking and follow-up; data management; quality assurance/
quality improvement; evaluation; partnerships; professional development
and recruitment, to include public education, outreach and inreach.
These components are carried out at the local, State and national
levels through collaborative partnerships with State health agencies,
community-based organizations, tribal governments, universities, a
variety of medical care providers and related agencies and
institutions, and the business and voluntary sectors. These partners
work together to develop, implement and evaluate strategies to promote
breast and cervical cancer prevention and early detection, to increase
access to related services and to improve the quality and timeliness of
the services.
A.3. National Program of Cancer Registries (NPCR)
The NPCR component supports efforts to establish population-based
cancer registries where they do not exist and to improve existing
cancer registries.
PA 02060 and applicable amendments, contain information that is
specific to the three individual components. Section G ``Specific
Guidance for NCCCP'' addresses the National Comprehensive Cancer
Control Program; Section H ``Specific Guidance for NCCEDP'' addresses
the National Breast and Cervical Cancer Early Detection Program; and
Section I ``Specific Guidance for NPCR'' addresses the National Program
of Cancer Registries. These component sections include specific
guidance regarding:
Eligibility
Program Requirements
Content
Other Requirements
Evaluation Criteria
Please refer to these specific component sections in PA 02060, and
amendments for information.
Special Guidelines for Technical Assistance
Conference Call: Technical assistance will be available for
potential applicants on a conference call that will be held on January
19, 2005, from 3:30 p.m. to 5:30 p.m. (Eastern time). Potential
applicants are requested to call in using only one telephone line. The
conference can be accessed by calling 1-888-576-9873, and entering the
passcode 21028.
The purpose of the conference call is to help potential applicants
to:
1. Understand the process for the Open Season Announcement for PA
02060 for the National Cancer Prevention and Control Program;
2. Understand the scope and intent of PA 02060 for the National
Cancer Prevention and Control Program;
3. Be familiar with the Public Health Services funding policies and
application and review procedures.
Participation in this conference call is not mandatory. At the time
of the call, if you have problems accessing the conference call, please
call 404-639-7550.
B. Eligible Applicants
Applicants may apply for any or all of the components within this
Open Season announcement for which they are eligible and that they are
not currently funded for under PA 02060.
B.1. Eligible for NCCCP
Potential applicants that are eligible for components of NCCCP are
the health departments of States or their bona fide agents, the
Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of
the Northern Mariana Islands, American Samoa, Guam, the Federated
States of Micronesia, the Republic of the Marshall Islands, and
Federally recognized Indian Tribal governments and Tribal
organizations, urban Indian organizations and inter-tribal consortia
(hereafter referred to as Tribes) whose primary purpose is to improve
American Indian/Alaska Native health and which represent the Native
population in their catchment area, that are not currently funded for
NCCCP under PA 02060.
B.2. Eligible for NBCCEP
Potential applicants that are eligible for NBCCEDP are the Virgin
Islands, the Commonwealth of the Northern Mariana Islands, the
Federated States of Micronesia, the Republic of the Marshall Islands,
and Federally recognized Indian Tribal governments and Tribal
organizations, urban Indian organizations and inter-tribal consortia
(hereafter referred to as Tribes) whose primary purpose is to improve
American Indian/Alaska Native health and which represent the Native
population in their catchment area, that are not currently funded for
NBCCEDP under PA 02060.
B.3. Eligible for NPCR
Potential applicants that are eligible for components of NPCR are
the health departments of States or their bona fide agents, the
Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the
Federated States of Micronesia, the Republic of the Marshall Islands,
and academic or nonprofit organizations designated by a State to
operate the State's cancer registry, that are not currently funded
under PA 02060.
Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant or loan.
C. Availability of Funds
Pending availability of FY 2005 funds, approximately $1,850,000 is
available in FY 2005 to fund new programs under the Open Season for PA
02060-FY05.
Awards under PA 02060 were made for a Project Period of September
30, 2002 through June 29, 2007. The first funding period was for the
period September 30, 2002 through June 29, 2003. The second funding
period was for the period June 30, 2003 through June 29, 2004. The
third funding period was for the period June 30, 2004 through June 29,
2005. Awards under this Open Season announcement will be for the Period
of June 30, 2005 through June 29, 2007, with funding for the period
June 30, 2005 through June 29, 2006. Future budget periods will be 12-
month periods, and will begin on June 30 of every year and run through
June 29 of each following year. These budget periods will occur until
the expiration of the project period for PA 02060, which is June 29,
2007.
In Accordance with G.2.d. of PA 2060, Amendment 4, there will be no
funding preferences applicable to this funding period.
All new applications will be reviewed through an Objective Review
process.
C.1. Component Funding
NCCCP $250,000
NBCCEDP $0 (No Open Season Funds Available for FY05)
[[Page 2409]]
NPCR $250,000
NCCCP--Additional Optional Funding available for recipients of
NCCCP Implementation Programs as follows:
Colorectal cancer activities $250,000
Ovarian cancer activities $500,000
Prostate cancer activities $500,000
Skin cancer activities $100,000
C.2. Requested Budget Information
Applicants should submit separate budgets for each component (as
well as separate budgets if applying for the Additional Optional
Funding under NCCCP) in response to this Open Season announcement. Each
detailed budget and narrative justification should support the
activities for the funding period specified in this Program
Announcement for FY 2005 support.
Applications should follow the guidance provided under each program
component in PA 02060 and applicable amendments, with respect to the
development and submission of an itemized budget and justification.
C.3. Use of Funds
For specific ``Use of Funds'' information, refer to Sections G, H,
and I of PA 02060 and amendments.
Cooperative agreement funds may be used to support personnel and to
purchase equipment, supplies, and services directly related to project
activities and consistent with the scope of the cooperative agreement.
Funds provided under this program announcement may not be used to:
Conduct research projects. Guidance regarding CDC's
definition of ``research'' should be reviewed at http: //http://www.cdc.gov/od/ads/opspoll1.htm
.
Supplant State or local funds, to provide inpatient care
or treatment, or to support the construction or renovation of
facilities.
Applicants are encouraged to identify and leverage mutually
beneficial opportunities to interact and integrate with other State
health department programs that address related chronic diseases or
risk factors. This may include cost sharing to support a shared
position such as a Chronic Disease Epidemiologist, Health Communication
Specialist, Program Evaluator, or Policy Analyst to work on relevant
activities across units/departments within the State health department.
Such activities may include, but are not limited to joint planning,
joint funding of complementary activities, public health education,
collaborative development and implementation of environmental, policy,
systems, or community interventions and other cost sharing activities.
C.4. Recipient Financial Participation
For specific ``Recipient Financial Participation'' information,
please refer to Sections G, H, and I of PA 02060 and amendments.
C.5. Direct Assistance
For specific ``Direct Assistance'' information, please refer to
Sections G, H, and I of PA 02060 and amendments.
C.6. Funding Preferences
In accordance with the ``Funding Preference'' section of the
amended PA 02060, no funding preference will be given for this period.
For specific ``Funding Preference'' information, please refer to
Sections G, H, and I of PA 02060 and amendments.
C.7. Funding Consideration
For specific ``Funding Consideration'' information, please refer to
Sections G, H, and I of PA 02060 and amendments.
D. Content
D.1. Letter of Intent
One Letter of Intent (LOI) is requested from each applicant
applying for any component(s) of this program. The narrative should be
no more than one single-spaced page, printed on one side, with one-inch
margins, and unreduced font. Your LOI will not be evaluated, but will
be used to assist CDC in planning for the objective review for this
program and should include the announcement number, the specific
component(s) and parts of the component, if applicable, for which funds
are being applied, and the name of the principal investigator.
D.2. Application Development
Please refer to Sections G, H, and I of PA 02060 and amendments to
use the information in the Program Requirements, Other Requirements,
and Evaluation Criteria sections to develop the application content.
Your application will be evaluated using the criteria listed, so it is
important to follow them in laying out your application.
Applications should follow the guidance below with respect to page
limitations for each component. All applications should be printed on
one side, with one-inch margins, using unreduced font. All materials
must be provided in an unbound, one-sided, 8\1/2\ x 11'' print format,
suitable for photocopying (i.e., no audiovisual materials, posters,
tapes, etc.).
D.3. Page Limitations
For specific ``Page Limitations'' information, please see Sections
G, H, and I of PA 02060 and amendments.
D.4. Application Outline
Applicants may apply for any or all of the components within this
program announcement for which they are eligible. Please provide
specific ``Application Outline'' information for each component as
outlined in specific Sections G, H, and I of PA 02060 and amendments.
E. Submission and Deadline
E1. Letter of Intent
On or before January 28, 2004, submit the LOI to the National
Center for Chronic Disease Prevention and Control.
By mail: Tanya Hicks, Program Analyst, CDC National Center for
Chronic Disease Prevention and Health Promotion, 4770 Buford Hwy, NE,
MS K-57, Atlanta, GA 30341-3717; or by courier service: Tanya Hicks,
Koger Center, 2858 Woodcock Blvd, Davidson Bldg, Room 2081, Chamblee,
GA 30341; or by fax: 770-488-3230; or by e-mail: Thicks@cdc.gov.
E.2. Application
Submit the original and two copies of CDC Form 0.1246. Forms are
available in the application kit and at the following Internet address:
http://www.cdc.gov/od/pgo/forminfo.htm.
On or before February 28, 2005, submit the original and two copies
of the application to: Technical Information Management--PA02060FY05,
Procurement and Grants Office, Centers for Disease Control and
Prevention, 2920 Brandywine Road, Atlanta, GA 30341-4146.
Applications may not be submitted electronically at this time.
Please reference Program Announcement Number 02060-FY05 National
Cancer Prevention and Control Program on the mailing envelope and on
the application Standard Form 424, block 11. Please also make sure that
block 16 on Standard Form 424 regarding Executive Order 12372 has been
completed correctly.
E.3. Deadline
Applications must be received in the CDC Procurement and Grants
Office by 4 p.m. Eastern time on the deadline date. If you send your
application by the United States Postal Service of commercial delivery
service, you must ensure that the carrier will be able to guarantee
delivery of the application by the closing date and time. If CDC
receives your application after closing due to: (1) Carrier error, when
the carrier accepted the package with a guarantee for delivery by the
closing date and time, or (2) significant weather delays or natural
disasters, you will be
[[Page 2410]]
given the opportunity to submit documentation of the carriers
guarantee. If the documentation verifies a carrier problem, CDC will
consider the application as having been received by the deadline.
CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: 770-488-2700. Before calling, please wait two to three days after
the application deadline. This will allow time for the applications to
be processed and logged.
F. Evaluation Criteria
Each application will be evaluated individually will be reviewed
through an Objective Review process.
For specific ``Evaluation Criteria'' information, please see
Sections G, H, and I of PA 02060 and amendments.
G. Where To Obtain Additional Information
This and other CDC announcements can be found on the CDC home page
Internet address--http://www.cdc.gov. Click on ``Funding'' then
``Grants and Cooperative Agreements.''
If you have questions after reviewing the contents of all the
documents, business management technical assistance in the states may
be obtained from: Annie Camacho or Glynnis Taylor, Grants Management
Specialist, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341-4146, Telephone number: Annie Camacho: 770-488-2735,
Glynnis Taylor: 770-488-2752, E-mail address: Annie Camacho:
atc4@cdc.gov, Glynnis Taylor: gld1@cdc.gov.
Business management technical assistance in the territories may be
obtained from: Vincent Falzone, Grants Management Specialist, CDC
Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341-
4146, Telephone number: 770-488-2763, E-mail address: vcf6@cdc.gov.
For program technical assistance contact:
NCCCP: Leslie S. Given, M.P.A., Public Health Advisor, NCCCP,
Program Services Branch, Division of Cancer Prevention and Control,
National Center for Chronic Disease Prevention and Health Promotion,
Centers for Disease Control and Prevention, 4770 Buford Hwy., NE (MS K-
57), Atlanta, GA 30341-3717, Telephone number: 770-488-3099, E-mail
address: llg5@cdc.gov.
NBCCEDP: Susan True, M.Ed., Branch Chief, Program Services Branch,
Division of Cancer Prevention and Control, National Center for Chronic
Disease Prevention and Health Promotion, Centers for Disease Control
and Prevention, 4770 Buford Hwy., NE (MS K-57), Atlanta, GA 30341-3717,
Telephone number: 770-488-4880, E-mail address: smt7@cdc.gov.
NPCR: Lois Voelker, Public Health Advisor, Cancer Surveillance
Branch, Division of Cancer Prevention and Control, National Center for
Chronic Disease Prevention and Health Promotion, Centers for Disease
Control and Prevention, 4770 Buford Hwy., NE (MS K-53), Atlanta, GA
30341-3717, Telephone number: 770-488-3095, E-mail address:
lvoelker@cdc.gov.
Dated: January 5, 2005.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-488 Filed 1-12-05; 8:45 am]
BILLING CODE 4163-18-P